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ABSTRACT
Cow’s milk protein allergy (CMPA) is a food allergy mostly suffered by children aged < 3 years that can be 
mediated by IgE or non-IgE or both. The prevalence of CMPA in children is heterogeneous between populations. 
Meta-analysis study showed that the prevalence was 2-3% in infants and < 1% in children aged < 6 years. 
Although the prevalence is quite small but proper management is very important because it affects the quality 
of life of children and to avoid the risk of anaphylactic reaction that threatens life. Therapy for CMPA is to 
avoid cow's milk protein and its derivatives; it is also recommended for breast-feeding mothers to do the same. 
Therapeutic milk formulas that can be given is extensively hydrolyzed formula (eHF) or soy infant formula (SIF). 
The selection of formula became adebate, especially about the safety, effectiveness and cost. 
Keywords: cow milk protein allergy, soy infant formula, extensively hydrolyzed formula
ABSTRAK
Alergi susu sapi (ASS) merupakan alergi makanan yang paling banyak diderita oleh anak dibawah usia 3 
tahun yang dapat diperantarai oleh IgE atau Non-IgE atau keduanya. Prevalensi ASS pada anak-anak bervariasi 
di berbagai populasi. Penelitian meta-analisis menunjukkan prevalensi sebesar 2-3% pada bayi dan < 1% pada 
anak dibawah usia 6 tahun. Meskipun memiliki prevalensi yang cukup kecil, tatalaksana yang tepat sangat 
SHQWLQJNDUHQDPHPSHQJDUXKLNXDOLWDVKLGXSDQDNGDQPHQJKLQGDULUHVLNRUHDNVLDQD¿ODNWLN\DQJPHQJDQFDP
nyawa. Terapi untuk ASS adalah menghindari protein susu sapi dan semua produk turunannya. Ibu menyusui 
juga direkomendasikan untuk melakukan hal yang sama. Susu formula terapeutik yang dapat diberikan adalah 
susu soya dan susu terhidrolisis ekstensif. Pemilihan formula menjadi pembahasan terutama tentang keamanan, 
efektivitas dan biaya.
Kata kunci: alergi susu sapi, susu soya, susu terhidrolisis ekstensif
INTRODUCTION
)RRGDOOHUJ\LVGH¿QHGDVDGYHUVHHIIHFWVRQKHDOWK
EHFDXVHRIWKHVSHFL¿FLPPXQHUHVSRQVHLQGXFHGE\
food.1 Cow milk protein allergy is the most common 
IRRGDOOHUJLHVVXIIHUHGE\FKLOGUHQDJHG\HDUV 
Cow milk protein allergy in children can be mediated 
E\,J(RUQRQ,J(RUERWK2QHVWXG\UHSRUWHG
of cases mediated by IgE.4
Cow milk protein allergy (CMPA)in children have a 
heterogeneous prevalence between populations. Meta-
DQDO\VLVVWXGLHVLQ(XURSHVKRZDSUHYDOHQFHRI
LQ LQIDQWVDQGLQFKLOGUHQDJHG\HDUV 
Other studies showed that CMPA in infants were 
ZLWKV\PSWRPVDSSHDUHGLQWKH¿UVW
4 months of life.7-11 One cohort study reported CMPA 
SUHYDOHQFHZDVLQFKLOGUHQDJHG\HDUDQG
WKHVDPHUDWLRZDVIRXQGLQDODUJHUVWXG\ZLWK
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month follow up.5,11,12 Study in Israel reported that the 
LQFLGHQFHRI&03$LQLQIDQWVZHUHDQG
LQFKLOGUHQDJHG\HDUVROGZLWKKLJKHUSUHYDOHQFH
found in boys compared to girls.
Natural tolerance of CMPA can occur in children. 
,QWROHUDQFHPD\RFFXUE\LQWKH¿UVW\HDU
LQWKHVHFRQG\HDULQWKHWKLUG\HDULQ
WKH IRXUWK \HDU DQG FDQ UHDFK LQ VL[WK\HDU9,15 
Even in a study conducted in different populations, 
the tolerance rates were found to be higher.16 CMPA 
has wide range of symptoms from gastrointestinal, 
skin to respiratory symptoms.17 Symptoms that arise 
due to this allergy range from mild to severe and even 
life-threatening reactions, such as anaphylaxis reaction 
that might compromise respiratory and cardiovascular 
system.17 Cow's milk is the third most common food 
that can cause anaphylactic reactions after peanuts 
DQG WUHH QXWV RI DQDSK\OD[LV FDVHVZKLFK
occur due to food are caused by cow’s milk. Despite 
the low prevalence and natural tolerance thatoccur 
concurrently with the increased age, the risk of severe 
life-threatening anaphylaxis arestillpresent.17-21 There 
has been a lot of debate on therapeutic formula feeding 
recommendations in CMPA children that have been 
used as therapy. The debate are about the time of 
administration, safety issue, and cost. 
COW’S MILK PROTEIN ALLERGY: DIAGNOSIS AND 
MANAGEMENT
Management of cow’s milk protein allergy (CMPA) 
consists of diagnosis and therapy in children with 
CMPA. Diagnosis can be performed in children by 
dietary elimination of cow's milk protein, standardized 
RUDO FKDOOHQJH WHVW ,J( VSHFL¿F WHVW VNLQ WHVW DQG
patch test. The gold standard for diagnosing CMPA 
is standardized oral challenge test. Although gold 
VWDQGDUG LV DYDLODEOH LW LV VWLOO GLI¿FXOW WR GLDJQRVH
CMPA. Many clinicians diagnose CMPA based on the 
signs and symptoms17, 21
Therapy in children with CMPA is to avoid the 
allergens which is cow's milk protein. In breastfed 
children it is recommended that the mothers also 
avoid the consumption of cow's milk protein and 
its derivatives. In children with milk formula we 
can give therapeutic formula which are extensively 
hydrolyzed formula (eHF), amino acid formula 
(AAF), or soya infant formula (SIF) with isolated 
soy-based protein.17,21 Each formula has its own 
indications, advantages and disadvantages.17,21 There 
are much debate going on about the administration of 
SIF and eHF in children with CMPA. The debate are 
about safety of SIF, cost and palatability of eHF, and 
the effectiveness comparability between the two of 
them.
FORMULA RECOMMENDATION ON CHILDREN 
WITH CMPA 
Soy allergies in children are less common than 
CMPA.24$OWKRXJKPRUH UDUH RI FKLOGUHQ
with CMPA arealso allergic to soy.21,25,26 Studies by 
Klemola et al showed that adverse reactions to soy 
was more often to be found in children with cow milk 
allergy on age less than 6 months but after followed for 
2 years soy sensitization was not higher than children 
with eHF.25 
Prospective study in healthy infants comparing 
breastmilk, cow's milk formula and SIF by Halpern 
UHSRUWHG DOOHUJLF UHVSRQVH  WR VR\ DQG 
to cow’s milk.27 This study was also consistent with 
VWXG\E\)RPRQZKRIRXQGRIDGYHUVHHIIHFWVLQ
infants given SIF. National survey in the US reported 
WKDWWKHLQFLGHQFHRI&03$LVDQGVR\DOOHUJLHV
DUH29 There are two double-blind studies with 
SODFHER FRQWUROV UHSRUWHG VR\ DOOHUJ\ E\  DQG
(YHQUHFHQWVWXG\VKRZHGWKDWFKLOGUHQ
with IgE-mediated CMPA could tolerate soy. A double-
blind clinical study with placebo control by Zeigler was 
DOVRFRQVLVWHQWZLWKWKH¿QGLQJRILQIDQWVZLWK
IgE-mediated CMPA weretolerant to soy.
European Society for Pediatric Gastroenterology, 
Hepatology, and Nutrition (ESPGHAN) guideline 
considering the transition to SIF in infants after the age 
of 6 months due to an allergic reaction in children with 
CMPA to soy is more often to be found in children aged 
< 6 month.17,21 American Academy of Pediatrics (AAP) 
states SIF administration can be given to children with 
CMPA and mature infants.17,21 SIF administration are 
SURYHQQRWEHQH¿FLDOLQWKHSUHYHQWLRQRIDWRSLFGLVHDVH
in healthy infants or high risk infants. AAP does 
not recommend SIF in CMPA children with enteropathy 
or cow’s milk protein-induced enterocolitis because 
 LQIDQWVZLWK FRZ
VPLON SURWHLQLQGXFHG
enterocolitis also experienced enterocolitis induced by 
soy. Enterocolitis cases induced by cow's milk 
and SIF reported from a preliminary study conducted 
RQVXEMHFWVZHUHDQGUHVSHFWLYHO\7KLV
FRQGLWLRQPD\EHFRPHWROHUDQFHE\LQFRZ
VPLON
DQGLQ6,)ZLWKWKHPDMRULW\RISDWLHQWVWROHUDQW
LQDJH\HDUV AAP also recommends that amino 
DFLGVIRUPXODFDQEHFRQVLGHUHGDVWKH¿UVWOLQHLQWKH
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case of severe signs and symptoms such as enterocolitis 
with hypoproteinemia and failure to thrive or severe 
anaphylatic cases.17,21
Adverse reactions of SIF administration are 
enteropathy, enterocolitis, proctitis, injury to the small 
intestine villi, malabsorption, hypoalbuminemia and 
failure to thrive. These adverse reactions have been 
found in at least 4 studies. Signs of enterocolitis can 
be found in the form of bloody diarrhea, ulceration, 
KLVWRORJ\IHDWXUHRILQÀDPPDWRU\ERZHOGLVHDVH,%'
acute or chronic. This is expected because theinjured 
intestinal mucosa due to cow's milk increases the 
uptake of soy protein in the gut, thus enhancing the 
immunological response to soy antigen. Eosinophilic 
proctitismay also befound in children who receive 
SIF.
Soya infant formula is a rational choice for mature 
infants if breastfeeding is not possible and intolerance 
to cow's milk is present. Another indications of SIF 
DUH JDODFWRVHPLD KHUHGLWDU\ ODFWDVH GH¿FLHQF\ DQG
conditions that require vegetarian diet.17,21 Education 
and good communication can convince caregivers that 
colic usually disappears spontaneously at the age of 4-6 
months. Colic is not an indication of SIF administration 
although some reports stated that it may reduce colic 
complaints.44-46
In children with age less than 12 months, eHF with 
casein and whey base are well tolerated.17,21,47eHF 
is defined as formula containing peptide with a 
PROHFXODUZHLJKW'DZKLFKGRHVQRWWULJJHU
DOOHUJLF UHDFWLRQV LQ RI FDVHV RI FKLOGUHQZLWK
CMPA.21,47 However, there are some children who 
QHHGDPLQRDFLGIRUPXODEHFDXVHWKH\FDQQRW
tolerate eHF. Formula feeding in children with CMPA 
should consider several things, such as the potential 
for allergies, formula composition, cost, children 
tolerance, and clinical data that show the effectiveness 
of formula.17 In case of CMPA with severe signs and 
V\PSWRPV$$)FDQEHFRQVLGHUHGDV WKH¿UVW OLQH
while in mild to moderate CMPA, eHF is preferable 
than SIF. In case the children cannot tolerate eHF, SIF 
is a rational and safe choice.
SOY INFANT FORMULA: INDICATION AND SAFETY 
ISSUES
Soy infants formula (SIF) administration is often 
debated because although it does not contain cow's 
PLONSURWHLQFKLOGUHQDOOHUJ\WRFRZ¶VPLON
are also allergic to soy, and enterocolitis due to soy 
DOVRRFFXULQ&03$FKLOGUHQZLWKFRZ¶VPLON
protein-induced enterocolitis.This condition 
often become clinician's consideration when giving 
SIF because despite the low prevalence of soy allergy, 
there remains a possibility of severe anaphylaxis risk 
that can be life threatening. Recommendation from the 
AAP and EPSGHAN state that SIF is a rational choice 
DQGFDQEHMXVWL¿HGLQ&03$FKLOGUHQ17,21
Current SIF is based on isolated soy protein and is 
GLIIHUHQWIURP\HDUVDJRVR\IRUPXODZLWKVR\ÀRXU
DVEDVHGSURWHLQ&XUUHQWO\6,)FRQWDLQVGLIIHUHQW¿EHU
phytate, digestibility, protease inhibitors and proteins 
than the old one. SIF is easily digestible and contain 
KLJKDPLQRDFLGFRQWHQWIRUWL¿HGZLWK/PHWKLRQLQH
L-carnitine and taurine. High content of phytate is 
RYHUFRPHZLWK]LQFDQGLURQIRUWL¿FDWLRQDVZHOODV
increased levels of calcium and phosphor; phytate may 
cause impaired absorption of minerals. The content of 
SURWHDVHLQKLELWRUVKDYHDOVREHHQUHGXFHGXSWR
([LVWLQJGH¿FLHQFLHVLQWKHROGVR\IRUPXODLVLPSURYHG
in modern SIF.22
SIF showed no significant difference when 
compared to cow's milk formula and breast milk with 
parameters such as body length, weight and head 
circumference.22,49 However, children with breast milk 
have cognitive development that isslightly better than 
those with formula milk.49Another study also found no 
differences in bone mineralization between breast milk 
and SIF with cow's milk formula.It is also stated 
that SIF correlation with sexual development, thyroid 
disease, immune function, as well as high levels of 
aluminum is not a safety issue.21Current study cannot 
prove that SIF cause hypothyroidism in children with 
euthyroid conditions, disorders of sexual development 
also has not been proven, aluminum levels in infant 
formula though high but still within the limits allowed 
by Food and Agriculture Organization of the United 
Nation (FAO) and World Health Organization (WHO). 
U.S. Food and Drug Agency (FDA) also stated that 
SIF is safe.Soya infants formula should not be given 
to premature infants or infants with impaired renal 
function.21,22
The correlation between SIF and hypothyroidism 
was studied by Messina et al. The study analyzed many 
other studies that examined the relationship between 
WKHHIIHFWVRIVR\RULVRÀDYRQHVRQWK\URLGIXQFWLRQ
of healthy subjects. This study found no effect or only 
DYHU\OLPLWHGHIIHFW7KLVVWXG\H[DPLQHGVWXGLHV
with women as sample, 4 studies with men as sample 
and 2 studies with both as sample.54 AAP states that in 
children with congenital hypothyroidism, they require 
levothyroxine dose enhancement due to phytate that 
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inhibit the absorption of thyroxine.55,56 Nevertheless, in 
WKHFDVHRIHXWK\URLGWKHWK\URLGKRUPRQHGH¿FLHQF\
was not found in subjects who consumed soy.21,54
Sexual development and hormonal disorders 
often become safety issues on SIF administration that 
cause many studies trying to prove the correlation 
between high isoflavone in SIF and its active 
metabolite in blood.21,22 Isofavone is phytoestrogens 
that hypothetically may cause disruption of sexual 
development and disorders of hormonal development 
LQLQIDQW,VRÀDYRQHVDUHIRXQGLQWKHXPELOLFDOEORRG
RILQIDQWVLQDVWXG\WKDWSURYHGLVRÀDYRQHVFRXOGSDVV
through the placental barrier. Further study also found 
WKDWLVRÀDYRQHOHYHOVLQLQIDQWVZKRUHFHLYHVR\ZHUH
hundreds of times higher than children who did not. 
This study also suggested that high levels of soy could 
QRWEHOLQNHGWRZKHWKHUWKHDFWLYLW\RIWKHLVRÀDYRQHV
in the body of the infant were also high. This is because 
high levels and bioactivity are two different things.57-60
Many studies in animals and mice claimed that soy 
ZDVVLJQL¿FDQWO\SURYHQWRDIIHFWVH[XDOGHYHORSPHQW
in mice. Study reported that the metabolism of 
LVRÀDYRQHV LQ WKH EORRG LQ WKH IRUP RI JHQLVWHLQ
daidzein and glycitein in animals, especially rodents 
were very different compared to metabolism in 
humans.61 The active metabolite in humans or non-
FRQMXJDWHGLVRÀDYRQHVLQDGXOWVDQGLQIDQWVLVLQD
VWDEOHFRQGLWLRQDQGDWSHDNV61 This is incontrast 
to mice that were proven to be 20-150 higher than that 
of human adults and infants. The study concluded that 
WKHPHWDEROLVPRILVRÀDYRQHVLQKXPDQVDQGDQLPDOV
did not show any correlation and thus, it was concluded 
that soy interference with sexual development and 
hormonal should not be drawn from the study in 
animal especially rodent.61 Although at 2010 one study 
UHSRUWHGDSRVVLEOHDVVRFLDWLRQEHWZHHQXWHULQH¿EURLGV
and SIF with a risk ratio of 1.25 but when calculated 
ZLWKDFRQ¿GHQFHLQWHUYDOWKHULVNUDWLRZHUH
VRWKHULVNUDWLRZDVQRWVLJQL¿FDQW62
There were two randomized controlled clinical 
studies and one cohort study that examined the 
correlations between immune function, the risk of 
respiratory infections and gastrointestinal tract to SIF 
administration. These studies stated that SIF, breast 
PLONDQGFRZ
VPLONIRUPXODGLGQRWGLIIHUVLJQL¿FDQWO\
with parameter such as B lymphocytes, T lymphocytes, 
IgA, IgG and IgM from poliovirus, diphtheria or 
+DHPRSKLOXVLQÀXHQ]DH(SLVRGHVRIUHVSLUDWRU\WUDFW
infections and acute diarrhea were also similar. This 
study was also supported by the AAP, SIF does not 
interfere with oral immunization of polio vaccine.21 
Current study has not or cannot prove SIF associated 
immune system disorders in children.21,22 Recent years 
study found that modern SIF administration was not 
VLJQL¿FDQWO\GLIIHUHQWWRWKHRWKHUPLONZLWKSDUDPHWHU
such as growth, calcium levels, hemoglobin levels and 
protein concentration.21,22
EXTENSIVELY HYDROLYZED FORMULA: 
INDICATION AND SAFETY ISSUES
([WHQVLYHO\K\GURO\]HGIRUPXODH+)LVGH¿QHGDV
formula containing peptides with a molecular weight 
'D7KHUHDUHH+)EDVHVZKH\SURWHLQDQG
casein protein. These protein are proved to be safe 
DQG WROHUDEOH LQ RI&03$FKLOGUHQZLWK 
FRQ¿GHQFHLQWHUYDO21,476WXGLHVLQVWDWHGWKDWH+)
ZDVEHQH¿FLDOWRSUHYHQWDWRS\GLVHDVHVDQG&03$LQ
children aged 4-6 months who did not get exclusive 
breastfeeding.
Administration of eHF is only slightly better than 
partial hydrolyed formula, however no conclusive 
result on this matter. Study by Vandenplas et al found 
WKDW H+)PHDQLQJIXOO\ DQG VLJQL¿FDQWO\ UHGXFH WKH
symptoms of CMPA.67 This study examined eHF in 
children suspected with CMPA that test positive or 
negative from standardized oral challenge. Symptom 
score reduction was found in both groups with the 
ODUJHVWVFRUHGHFOLQHLQ&03$FRQ¿UPHGFKLOGUHQ67
Hydrolyzed formula are proven to prevent atopy 
diseases and CMPA in children,but further studies are 
still needed.It is also shown to reduce symptoms 
DQGWKHODUJHVWVFRUHGHFOLQHVLVLQ&03$FRQ¿UPHG
children.67 This shows that eHF is also a rational 
choice for CMPA children.The cost of eHF is 
also an important problem as it is not cost effective 
when compared with other formula milk.17,21 Cost is 
a problem, particularly in developing countries so the 
sustainability could not be achieved.
CONCLUSION
The debate about the safety issue on SIF ranging 
from levels of aluminium, phytate, corellation of 
LVRÀDYRQH DQG VH[XDO GHYHORSPHQW GLVRUGHUV ERQH
mineralization, immune system, endocrine and 
infection. Many studies showing contradictory results 
in this regard, but recent studies showed that all of 
these were not proven and inconclusive. In regard to 
this, the administration of SIF is safe and cost effective 
for mature CMPA children if the children cannot 
tolerate eHF. However giving therapeutic formula 
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ZLWKRXW LQGLFDWLRQ FDQQRW EH HDVLO\ MXVWL¿HG ,Q WKH
end, therapeutic formula feeding in children should 
take the tolerance of child, potential allergies and costs 
into account. 
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